Trabikibart is a fully human betac-specific monoclonal antibody, designated CSL311, that binds with picomolar affinity to the cytokine-binding epitope of the human betac receptor. Trabikibart exhibits potent inhibitory activity against the collective biological effects of IL-3, GM-CSF, and IL-5 on eosinophil survival, positioning it as a promising biologic agent for the study of chronic inflammatory and eosinophil-associated disorders.
Reinheit:
99.30%
CAS Nummer:
[2643974-98-3]
Target-Kategorie:
c-Fms|||IL Receptor
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
